Healthcare provider profile · identity verified

Michael D Achey, MD

Internal Medicine · TAUNTON, MA · NPI 1578574703

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	590	178
Lisinopril	Lisinopril	400	122
Lorazepam	Lorazepam	357	63
Metoprolol Succinate	Metoprolol Succinate	319	100
Omeprazole	Omeprazole	296	90
Amlodipine Besylate	Amlodipine Besylate	271	81
Rosuvastatin Calcium	Rosuvastatin Calcium	267	95
Losartan Potassium	Losartan Potassium	253	73
Alprazolam	Alprazolam	252	45
Levothyroxine Sodium	Levothyroxine Sodium	229	63
Metformin Hcl Er	Metformin Hcl	212	63
Oxycodone Hcl	Oxycodone Hcl	191	29
Pravastatin Sodium	Pravastatin Sodium	181	62
Gabapentin	Gabapentin	180	48
Eliquis	Apixaban	176	37
Tramadol Hcl	Tramadol Hcl	153	31
Albuterol Sulfate Hfa	Albuterol Sulfate	152	54
Famotidine	Famotidine	147	43
Prednisone	Prednisone	130	74
Hydrochlorothiazide	Hydrochlorothiazide	129	44
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	126	17
Simvastatin	Simvastatin	124	36
Fluoxetine Hcl	Fluoxetine Hcl	118	32
Trazodone Hcl	Trazodone Hcl	115	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	113	20
Pantoprazole Sodium	Pantoprazole Sodium	111	27
Doxazosin Mesylate	Doxazosin Mesylate	104	34
Meloxicam	Meloxicam	100	27
Allopurinol	Allopurinol	92	30
Tamsulosin Hcl	Tamsulosin Hcl	92	34
Celecoxib	Celecoxib	87	27
Morphine Sulfate Er	Morphine Sulfate	87	suppressed
Pregabalin	Pregabalin	80	16
Furosemide	Furosemide	78	28
Diazepam	Diazepam	75	14
Quetiapine Fumarate	Quetiapine Fumarate	74	14
Sertraline Hcl	Sertraline Hcl	74	25
Escitalopram Oxalate	Escitalopram Oxalate	72	29
Metformin Hcl	Metformin Hcl	72	29
Atenolol	Atenolol	70	23
Mirtazapine	Mirtazapine	70	23
Ibuprofen	Ibuprofen	69	17
Warfarin Sodium	Warfarin Sodium	63	12
Finasteride	Finasteride	61	21
Alendronate Sodium	Alendronate Sodium	59	20
Clonazepam	Clonazepam	59	14
Duloxetine Hcl	Duloxetine Hcl	58	17
Pioglitazone Hcl	Pioglitazone Hcl	58	17
Aripiprazole	Aripiprazole	56	suppressed
Paroxetine Hcl	Paroxetine Hcl	54	14
Ropinirole Hcl	Ropinirole Hcl	53	11
Zolpidem Tartrate	Zolpidem Tartrate	53	suppressed
Clopidogrel	Clopidogrel Bisulfate	51	14
Baclofen	Baclofen	50	16
Bumetanide	Bumetanide	49	18
Metoprolol Tartrate	Metoprolol Tartrate	45	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	17
Montelukast Sodium	Montelukast Sodium	44	13
Ventolin Hfa	Albuterol Sulfate	44	14
Triamcinolone Acetonide	Triamcinolone Acetonide	43	24
Xarelto	Rivaroxaban	42	suppressed
Ezetimibe	Ezetimibe	41	suppressed
Ozempic	Semaglutide	41	suppressed
Benazepril Hcl	Benazepril Hcl	40	11
Glimepiride	Glimepiride	40	15
Spironolactone	Spironolactone	40	suppressed
Trospium Chloride	Trospium Chloride	40	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Buspirone Hcl	Buspirone Hcl	38	11
Jardiance	Empagliflozin	35	14
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Lovastatin	Lovastatin	34	12
Meclizine Hcl	Meclizine Hcl	34	11
Donepezil Hcl	Donepezil Hcl	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	15
Citalopram Hbr	Citalopram Hydrobromide	32	11
Felodipine Er	Felodipine	32	11
Naproxen	Naproxen	32	suppressed
Potassium Chloride	Potassium Chloride	32	12
Propranolol Hcl	Propranolol Hcl	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Topiramate	Topiramate	27	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	13
Ipratropium Bromide	Ipratropium Bromide	26	12
Eszopiclone	Eszopiclone	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Doxepin Hcl	Doxepin Hcl	24	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	14
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Nystatin	Nystatin	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Glipizide	Glipizide	20	11
Mounjaro	Tirzepatide	20	suppressed
Primidone	Primidone	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	11
Hydrocortisone	Hydrocortisone	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Varenicline Tartrate	Varenicline Tartrate	18	suppressed
Estradiol	Estradiol	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Nifedipine Er	Nifedipine	16	suppressed
Dilt-Xr	Diltiazem Hcl	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Minocycline Hcl	Minocycline Hcl	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Torsemide	Torsemide	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Risperidone	Risperidone	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Triazolam	Triazolam	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error